Organisation: UniPhar Group

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

HSE pays out €484m to drug firms under scheme

One drug firm received fees over €225m from the HSE through the executive’s High Tech Drugs and Medicines scheme in 2014, new figures show.

Fri, 01 Apr, 2016

UniPhar announces merger details

UniPhar Group today announced the forthcoming merger of its two successful surgical business units, Whelehan Surgical and Surgicare.

Mon, 27 Aug, 2007

O’Malley denies conflict of interest over drug shares

Jim Morahan

Tue, 30 Aug, 2005

UniPhar cleared to acquire Ammado

The Competition Authority announced today (15th July) that it will allow the proposed acquisition by UniPhar plc (the parent company of the UniPhar Group) of Ammado Limited, (the holding company for the Whelehan Group).

Thu, 15 Jul, 2004